Metabolomic Technologies Formed to Commercialize Test for Colon Polyps; Partners with BGI | GenomeWeb

NEW YORK (GenomeWeb News) – The University of Alberta, the Alberta government, and BGI Shenzhen are collaborating on accelerating the commercialization of a new metabolomics-based test for detecting pre-cancerous polyps with the formation of a new company, they announced today.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: intellectual property landscape of CRISPR genome editing, and more.

A researcher has been convicted of conspiring to steal genetically engineered rice, Reuters reports.

Harvard Medical School's George Church says a woolly mammoth-elephant hybrid is only a few years away, according to the New Scientist.

Intel is ending its sponsorship of the International Science and Engineering Fair, the New York Times reports.